Literature DB >> 18721174

Reported lifetime aberrant drug-taking behaviors are predictive of current substance use and mental health problems in primary care patients.

Michael F Fleming1, James Davis, Steven D Passik.   

Abstract

BACKGROUND: The aim of this report is to determine the frequency of aberrant drug behaviors and their relationship to substance abuse disorders in a large primary sample of patients receiving opioids for chronic pain.
METHODS: The data utilized for this report was obtained from 904 chronic pain patients receiving opioid therapy from their primary care physician. A questionnaire was developed based on 12 aberrant drug behaviors reported in the clinical literature. The diagnosis of a current substance use disorder was determined using Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition(DSM-IV) criteria.
RESULTS: The average duration of chronic pain in the sample was 16 years and for opioid therapy, 6.4 years. Of the patients, 80.5% reported one or more lifetime aberrant drug behaviors. The most frequent behaviors reported included early refills (41.7%), increase dose without physician consent (35.7%), and felt intoxicated from opioids (32.2%). Only 1.1% of subjects with 1-3 aberrant behaviors (N = 464, 51.2%) met DSM-IV criteria for current opioid dependence compared with 9.9% of patients with four or more behaviors (N = 264, 29.3%). Persons with positive urine toxicology tests for cocaine were 14 times more likely to report four or more behaviors than no behaviors (14.1% vs 1.1%). A logistic model found that subjects who reported four or more aberrant behaviors were more likely to have a current substance use disorder (odds ratio [OR] 10.14; 3.72, 27.64), a positive test for cocaine (odds ratio [OR] 3.01; 1.74, 15.4), an Addiction Severity Index (ASI) psychiatric composite score >0.5 (OR 2.38; 1.65, 3.44), male gender (OR 2.08: 1.48, 2.92), and older age (OR 0.69; 0.59, 0.81) compared with subjects with three or fewer behaviors. Pain levels, employment status, and morphine equivalent dose do not enter the model.
CONCLUSIONS: Patients who report four or more aberrant drug behaviors are associated with a current substance use disorder and illicit drug use, whereas subjects with up to three aberrant behaviors have a very low probability of a current substance abuse disorder. Four behaviors--oversedated oneself, felt intoxicated, early refills, increase dose on own--appear useful as screening questions to predict patients at greatest risk for a current substance use disorders.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18721174      PMCID: PMC2779534          DOI: 10.1111/j.1526-4637.2008.00491.x

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  29 in total

1.  Substance Dependence Severity Scale (SDSS): reliability and validity of a clinician-administered interview for DSM-IV substance use disorders.

Authors:  G M Miele; K M Carpenter; M Smith Cockerham; K D Trautman; J Blaine; D S Hasin
Journal:  Drug Alcohol Depend       Date:  2000-04-01       Impact factor: 4.492

2.  Adverse effects and cognitive function among primary care patients taking opioids for chronic nonmalignant pain.

Authors:  Randall T Brown; Megan Zuelsdorff; Michael Fleming
Journal:  J Opioid Manag       Date:  2006 May-Jun

3.  Overcoming fears, frustrations, and competing demands: an effective integration of pain medicine and primary care to treat complex pain patients.

Authors:  Matthew J Bair
Journal:  Pain Med       Date:  2007 Oct-Nov       Impact factor: 3.750

4.  Substance use disorders in a primary care sample receiving daily opioid therapy.

Authors:  Michael F Fleming; Stacey L Balousek; Cynthia L Klessig; Marlon P Mundt; David D Brown
Journal:  J Pain       Date:  2007-05-11       Impact factor: 5.820

5.  Validation and clinical application of the Screener and Opioid Assessment for Patients with Pain (SOAPP).

Authors:  Hammam Akbik; Stephen F Butler; Simon H Budman; Katherine Fernandez; Nathaniel P Katz; Robert N Jamison
Journal:  J Pain Symptom Manage       Date:  2006-09       Impact factor: 3.612

6.  Addiction Severity Index in a chronic pain sample receiving opioid therapy.

Authors:  Kenneth Saffier; Cynthia Colombo; David Brown; Marlon P Mundt; Michael F Fleming
Journal:  J Subst Abuse Treat       Date:  2007-03-21

7.  Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool.

Authors:  Lynn R Webster; Rebecca M Webster
Journal:  Pain Med       Date:  2005 Nov-Dec       Impact factor: 3.750

8.  Survey of select practice behaviors by primary care physicians on the use of opioids for chronic pain.

Authors:  Bhushan Bhamb; David Brown; Jaishree Hariharan; Jane Anderson; Stacey Balousek; Michael F Fleming
Journal:  Curr Med Res Opin       Date:  2006-09       Impact factor: 2.580

9.  Pain and aberrant drug-related behaviors in medically ill patients with and without histories of substance abuse.

Authors:  Steven D Passik; Kenneth L Kirsh; Kathleen B Donaghy; Russell K Portenoy
Journal:  Clin J Pain       Date:  2006-02       Impact factor: 3.442

10.  CAM therapies among primary care patients using opioid therapy for chronic pain.

Authors:  Sara Fleming; David P Rabago; Marlon P Mundt; Michael F Fleming
Journal:  BMC Complement Altern Med       Date:  2007-05-16       Impact factor: 3.659

View more
  17 in total

1.  Concurrent use of alcohol and sedatives among persons prescribed chronic opioid therapy: prevalence and risk factors.

Authors:  Kathleen W Saunders; Michael Von Korff; Cynthia I Campbell; Caleb J Banta-Green; Mark D Sullivan; Joseph O Merrill; Constance Weisner
Journal:  J Pain       Date:  2012-01-29       Impact factor: 5.820

2.  Aging: are these 4 pain myths complicating care?

Authors:  Stephen Thielke; Joanna Sale; M Carrington Reid
Journal:  J Fam Pract       Date:  2012-11       Impact factor: 0.493

3.  Alcohol and Drug Use and Aberrant Drug-Related Behavior Among Patients on Chronic Opioid Therapy.

Authors:  Cynthia I Campbell; Andrea H Kline-Simon; Michael Von Korff; Kathleen W Saunders; Constance Weisner
Journal:  Subst Use Misuse       Date:  2017-03-27       Impact factor: 2.164

4.  The association between catastrophizing and craving in patients with chronic pain prescribed opioid therapy: a preliminary analysis.

Authors:  Marc O Martel; Robert N Jamison; Ajay D Wasan; Robert R Edwards
Journal:  Pain Med       Date:  2014-03-10       Impact factor: 3.750

5. 

Authors:  Nav Persaud
Journal:  Can Fam Physician       Date:  2018-02-15       Impact factor: 3.275

6. 

Authors:  Nav Persaud
Journal:  Can Fam Physician       Date:  2018-02-15       Impact factor: 3.275

7.  Aberrant behaviors with prescription opioids and problem drug use history in a community-based cohort of HIV-infected individuals.

Authors:  Luke Hansen; Joanne Penko; David Guzman; David R Bangsberg; Christine Miaskowski; Margot B Kushel
Journal:  J Pain Symptom Manage       Date:  2011-07-30       Impact factor: 3.612

Review 8.  Opioid addiction and abuse in primary care practice: a comparison of methadone and buprenorphine as treatment options.

Authors:  Jean Bonhomme; Ruth S Shim; Richard Gooden; Dawn Tyus; George Rust
Journal:  J Natl Med Assoc       Date:  2012 Jul-Aug       Impact factor: 1.798

9.  Validation of a brief Opioid Compliance Checklist for patients with chronic pain.

Authors:  Robert N Jamison; Marc O Martel; Robert R Edwards; Jing Qian; Kerry Anne Sheehan; Edgar L Ross
Journal:  J Pain       Date:  2014-08-01       Impact factor: 5.820

Review 10.  Management of opioid medications in patients with chronic pain and risk of substance misuse.

Authors:  Seddon R Savage
Journal:  Curr Psychiatry Rep       Date:  2009-10       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.